An observational study in Abdominal Aortic Aneurysm, sponsored by Rijnstate Hospital. Completed at 1 site in Netherlands. Per ClinicalTrials.gov, last updated 2026-01-29.
Sponsored by Rijnstate Hospital · Observational
Retrospective single centre observational cohort study of patients who underwent an elective infrarenal abdominal aortic aneurysm repair, from January 2011 to January 2020.
Objective: To evaluate the performance of the Endurant endoprothesis in patients with a wide or conical shaped neck anatomy after elective abdominal aortic aneurysm repair.
Inclusion: Patients who underwent elective infrarenal abdominal aortic aneurysm repair with the Endurant endograft between January 2011 until January 2020 in Rijnstate, Arnhem, the Netherlands.
Primary endpoint: Freedom from reinterventions at one year.
Secondary outcomes:
473 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 100 are open to participants now.
This study's enrollment of 268 is above the median of 166 across 220 observational studies indexed under Aortic Aneurysm, Abdominal.
Browse Aortic Aneurysm, Abdominal studies →Rijnstate Hospital is the lead sponsor of 127 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients with an elective infrarenal endovascular abdominal aortic aneurysm repair with the Endurant endoprothesis between January 2011 till January 2020 in the Rijnstate hospital, Arnhem, the Netherlands.
All patients with an elective infrarenal endovascular abdominal aortic aneurysm repair with the Endurant endoprothesis between January 2011 till January 2020 in the Rijnstate hospital, Arnhem, the Netherlands.
Exclusion Criteria:
patients with an abdominal aortic aneurysm and a wide neck (\>28 mm diameter)
Procedure: EVAR
patients with an abdominal aortic aneurysm and a conical neck
Procedure: EVAR
patients with an abdominal aortic aneurysm without a wide or conical neck
Procedure: EVAR
endovascular repair of the AAA with the endurant stent graft
Freedom from reinterventions at one year
reintervention-free survival will be evaulated using kaplan meier method
Time frame: one year
Freedom from reinterventions throughout follow-up (up to ten years)
Reintervention-free survival throughout all available follow-up will be evaluated using kaplan-meier methods
Time frame: 10 years
Number of endoleaks
All endoleaks will be registered throughout follow-up and will be presented by type of endoleak.
Time frame: 10 year follow-up
the number of patients showing aneurysm sac growth
Sac growth is defined as growth over 5 mm and will be presented for 1 year follow-up, 5 years follow-up and 10 year follow-up
Time frame: 10 year follow-up
the number of patients with an aneurysm rupture during follow-up
all ruptures that occur will be registered including outcome (death or successful repair)
Time frame: 10 year follow-up
the number of patients showing stent migration
stent migration will be documented in mm and will be presented for 1 year follow-up, 5 years follow-up and 10 year follow-up
Time frame: 10 year follow-up
Number of patients with AAA related mortality
All deaths related to the AAA will be documented
Time frame: 10 year follow-up
the number of patients showing proximal fixation failure
proximal fixation failure is defined as yes if type 1 endoleak or stent migration or aneurysm sac growth will occur and will be presented for 1 year follow-up, 5 years follow-up and 10 year follow-up
Time frame: 10 year follow-up
All-cause mortality
all deaths will be registered regardless their cause
Time frame: 10 year follow-up
The number of patients with 30-day complications
All complications during the first 30 days will be registered related to the procedure and will be listed for the different types of complications
Time frame: 30 days
The number of patients with renal dysfunction/renal occlusion
all clinical relevant declines in renal function will be documented, including renal artery stenosis or occlusion
Time frame: 10 year follow-up
Plan to share: Undecided — On request we can decide if data can be shared; due to country and hospital policy, data transfer agreements need to be in place
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rijnstate Hospital